Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Christof Henne
Observed names:
C Henne,
Henne, Christof
Institution:
Medac (Germany)
Observed institution:
Medac (Germany)
ORCID:
0000-0002-3001-9090
Observed ORCID:
0000-0002-3001-9090
OpenAlex ID:
A5050456455
Intermediate and high-risk non-muscle-invasive bladder cancer: an overview of epidemiology, burden, and unmet needs
2023
·
Kristin Grabe-Heyne
, Christof Henne
, et al.
·
Frontiers in Oncology
·
123
PDF
Improved Therapeutic Approaches are Needed to Manage Graft-versus-Host Disease
2021
·
Deborah S. Hooker
, Kristin Grabe-Heyne
, et al.
·
Clinical Drug Investigation
·
12
PDF
Evaluating the cost-utility of intravesical Bacillus Calmette-Guérin versus radical cystectomy in patients with high-risk non-muscle-invasive bladder cancer in the UK
2023
·
Kristin Grabe-Heyne
, Christof Henne
, et al.
·
Journal of Medical Economics
·
11
EPH6 Non-Muscle-Invasive Bladder Cancer: A Review of Burden and Unmet Need
2022
·
K Grabe-Heyne
, C Henne
, et al.
·
Value in Health
EE563 Evaluating the Cost-Utility of Intravesical Bacillus Calmette-Guérin Versus Radical Cystectomy in Patients With High-Risk Non-Muscle-Invasive Bladder Cancer in the UK
2022
·
K Grabe-Heyne
, C Henne
, et al.
·
Value in Health
EE363 Improved Therapeutic Approaches Are Needed to Minimise the Burden of Graft-Versus-Host Disease
2022
·
D Hooker
, K Grabe-Heyne
, et al.
·
Value in Health
Show more works
View as search
Works count:
7
Citation count:
146
H-index:
3
I10-index:
3
Year
Topic
Type
